James Bloem Net Worth

The estimated Net Worth of James H Bloem is at least $9.96 Million dollars as of 7 November 2013. Mr. Bloem owns over 17,201 units of Gen Digital Inc stock worth over $1,013,947 and over the last 21 years he sold GEN stock worth over $8,946,832. In addition, he makes $0 as Independent Director at Gen Digital Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Bloem GEN stock SEC Form 4 insiders trading

James has made over 25 trades of the Gen Digital Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 17,201 units of GEN stock worth $2,924 on 7 November 2013.

The largest trade he's ever made was exercising 118,634 units of Gen Digital Inc stock on 14 March 2007 worth over $3,133,124. On average, James trades about 16,776 units every 75 days since 2003. As of 7 November 2013 he still owns at least 38,968 units of Gen Digital Inc stock.

You can see the complete history of Mr. Bloem stock trades at the bottom of the page.

James Bloem biography

James (Jim) H. Bloem serves as Independent Director of the Company. Mr. Bloem has served as a director and business consultant to various public and private companies, mainly in the health-care industry, since his retirement in 2013 after 13 years as Senior Vice President, Chief Financial Officer, and Treasurer of Humana, Inc. (“Humana”), one of the nation’s largest health-benefit companies. At Humana, he had responsibility for all of Humana’s accounting, actuarial, analytical, financial, tax, risk management, treasury, and investor relations activities. Mr. Bloem currently serves as a director of Rotech Healthcare, Inc. (publicly-held until 2012), a leading provider of home medical equipment and related services, where he serves as chairman of the audit committee. He also previously served as a director of Genesis Health Ventures, Inc. from 2001-2003 and NeighborCare from 2003-2005. Mr. Bloem’s financial background and experience qualify him as an “audit committee financial expert” under SEC rules.

How old is James Bloem?

James Bloem is 69, he's been the Independent Director of Gen Digital Inc since 2015. There are 1 older and 9 younger executives at Gen Digital Inc. The oldest executive at Gen Digital Inc is John DePodesta, 75, who is the Independent Director.

What's James Bloem's mailing address?

James's mailing address filed with the SEC is C/O GENESIS HEALTHCARE, INC., 101 EAST STATE STREET, KENNETT SQUARE, PA, 19348.

Insiders trading at Gen Digital Inc

Over the last 10 years, insiders at Gen Digital Inc have traded over $39,735,639 worth of Gen Digital Inc stock and bought 373,200 units worth $5,061,428 . The most active insiders traders include Peter A Feld, David A Reis, and Vincent Pilette. On average, Gen Digital Inc executives and independent directors trade stock every 37 days with the average trade being worth of $1,635,097. The most recent stock trade was executed by Vincent Pilette on 19 August 2024, trading 178,801 units of GEN stock currently worth $4,566,578.

What does Gen Digital Inc do?

​nortonlifelock inc. (nasdaq: nlok) is a global leader in consumer cyber safety with a growing portfolio of trusted and recognized brands. our award-winning products and services help protect and empower people to live their digital lives safely. nearly 80 million users in more than 150 countries trust us with their personal information. we’re dedicated to making it easy for them to keep their connected lives safer while helping to secure their devices, online privacy, identity, and home and family needs. ​nortonlifelock.com​norton.com​lifelock.com​avira.com

Complete history of Mr. Bloem stock trades at Gen Digital Inc and Humana

Gen Digital Inc executives and stock owners

Gen Digital Inc executives and other stock owners filed with the SEC include:

• George Hager,
  Chief Executive Officer, Director
• Robert Fish,
  Independent Director of the Board
• Thomas DiVittorio,
  Chief Financial Officer, Executive Vice President
• Paul Bach,
  Chief Operating Officer
• JoAnne Reifsnyder,
  Executive Vice President - Clinical Operations, Chief Nursing Officer
• Michael Sherman,
  Senior Vice President, General Counsel, Assistant Treasurer, Secretary
• Terry Rappuhn,
  Independent Director
• James McKeon,
  Independent Director
• John DePodesta,
  Independent Director
• James Bloem,
  Independent Director
• Arnold Whitman,
  Director
• Robert Hartman,
  Director
• Vincent Pilette,
  CEO & President
• Eric Brandt,
  Director
• Nora Denzel,
  Director
• Emily Heath,
  Director
• Sue Barsamian,
  Director
• Bryan Seuk Ko,
  CLO & Head Corp Aff
• Pavel Baudis,
  Director
• Corpschwartz Gerald Wonex P...,
  
• Robert A Reitz,
  EVP and COO
• Daniel Allen Hirschfeld,
  Pres. Genesis Rehab Services
• Rok Llc Op Co,
  10% owner
• Steven E. Fishman,
  Director
• David A Reis,
  Director
• Glenn S Schafer,
  Director
• Stephen Scott Young,
  SVP and Treasurer
• Joshua Hausman,
  Director
• M Bernard Puckett,
  Director
• Roland Rapp,
  General Counsel, CAO and Sec.
• Bruce A Yarwood,
  Director
• Linda Rosenstock,
  Director
• Chris Felfe,
  Chief Financial Officer
• John Todd Mitchell,
  SVP Chief Compliance Office
• Laurie Thomas,
  President Ancillary Business
• Michael Boxer,
  Director
• Paxton Wiffler,
  Chief Operating Officer
• Peter A Feld,
  Director
• Natalie Marie Derse,
  CFO
• Ondrej Vlcek,
  President
• Frank E Dangeard,
  Director
• Sherrese M Smith,
  Director